Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Dr. C H Weaver MD

  • Webinar: Making Sense of ctDNA Tests and What They Mean for Colorectal Cancer Care
    March 17, 2026

    Webinar: Making Sense of ctDNA Tests and What They Mean for Colorectal Cancer Care

    Dr. C H Weaver MD
  • FDA Grants Accelerated Approval to Zongertinib (Hernexeos) for Non-Squamous NSCLC with HER2 TKD Mutations
    March 16, 2026

    FDA Grants Accelerated Approval to Zongertinib (Hernexeos) for Non-Squamous NSCLC with HER2 TKD Mutations

    Dr. C H Weaver MD
  • Newly Diagnosed with Essential Thrombocythemia: FAQs
    March 11, 2026

    Newly Diagnosed with Essential Thrombocythemia: FAQs

    Dr. C H Weaver MD
  • Living with Cancer: Changing Seasons and the Emotional Shifts of Spring
    March 11, 2026

    Living with Cancer: Changing Seasons and the Emotional Shifts of Spring

    Dr. C H Weaver MD
  • Complementary and Alternative Medicine and Breast Cancer: How to Stay Safe While Exploring Your Options
    March 11, 2026

    Complementary and Alternative Medicine and Breast Cancer: How to Stay Safe While Exploring Your Options

    Dr. C H Weaver MD
  • ctDNA and MRD Testing in Bladder Cancer: FAQs
    March 10, 2026

    ctDNA and MRD Testing in Bladder Cancer: FAQs

    Dr. C H Weaver MD
  • ctDNA and MRD Testing in Breast Cancer: FAQs
    March 10, 2026

    ctDNA and MRD Testing in Breast Cancer: FAQs

    Dr. C H Weaver MD
  • Newly Diagnosed with Polycythemia Vera: FAQs
    March 7, 2026

    Newly Diagnosed with Polycythemia Vera: FAQs

    Dr. C H Weaver MD
  • ctDNA Testing May Help More Patients Preserve Their Bladder
    March 2, 2026

    ctDNA Testing May Help More Patients Preserve Their Bladder

    Dr. C H Weaver MD
  • ctDNA and MRD Testing in Lung Cancer: FAQs
    March 1, 2026

    ctDNA and MRD Testing in Lung Cancer: FAQs

    Dr. C H Weaver MD
  • New Treatment Combination Improves Outcomes for Bladder Cancer Patients Unable to Receive Standard Chemotherapy
    March 1, 2026

    New Treatment Combination Improves Outcomes for Bladder Cancer Patients Unable to Receive Standard Chemotherapy

    Dr. C H Weaver MD
  • FAQs: Molecular Residual Disease Testing in Colorectal Cancer
    February 27, 2026

    FAQs: Molecular Residual Disease Testing in Colorectal Cancer

    Dr. C H Weaver MD
Previous Page
1 2 3 4 5 … 382
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
Loading Comments...